by in
Entry Author Date Location
Ablexis Cuts Deal With Pfizer, Four Other Pharmas, For Antibody Drug Discovery Tool 10/26/10 San Francisco
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
ImmunoGen Gets $45M Upfront From Novartis To Make Souped Up Antibodies For Cancer 10/11/10 Boston
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies” 08/03/10 Seattle
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News 07/14/10 Boston
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
AnaptysBio Gets $1.5M from DARPA 07/12/10 San Diego
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
CMC Icos Mounts Comeback, Resumes Hiring, After Pausing During the Downturn 07/07/10 Seattle
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock, Pfizer 06/23/10 San Francisco
Seattle Genetics’ Dark Horse Drug Candidate Approaches Home Stretch in Leukemia Study 06/22/10 Seattle
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round 05/27/10 Boston
Signature Genomic Gets Sold for $90M, DreamBox Bought by Netflix CEO, The $7M Madrona Man, & More Seattle-Area Deals News 04/21/10 Seattle
The Hybritech Alumni: Where Are They Now? 03/12/10 San Diego
Seattle Genetics Gets Roche Cash 03/03/10 Seattle
Celldex CEO Treks From NJ to Massachusetts in Pursuit of Antibody Drugs for Cancer 02/23/10 Boston
Google Pours “Incredible” Computing Power into Antibody Drug Discovery With Adimab 02/03/10 Boston
Millennium, In a New Role, Flexes Global Muscle to Cut Deal With Seattle Genetics 01/26/10 Boston
Alnylam Maps Out First Steps in ‘RNA Decade’ 01/11/10 Boston
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
Page 3 of 4 « previous page · next page »